Product Pipeline

Our company has established the industry's most clinically advanced hUC-MSC product candidates based on our extensive R&D experiences in the development of hUC-MSC therapeutics over the past two decades.  We are dedicated to using hUC-MSC technologies to address the unmet medical needs in multiple difficult-to-treat diseases.

About Us                                                                                  Scientific Publications

Technology and Product                                                  Intellectual Property

Core Technologies

Product Pipeline                                                                   Partnerships

Rheumatoid Arthritis

Crohn's Disease                                                                     Mission

Advanced Cancer


                                                                                                      Contact Us


                                                                                                                                                                                                      © 2019 Baylx,Inc. All rights reserved.